News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Baxano Rapidly Expands Sales Force to Support Robust Demand for the iO-Flex(R) System



10/31/2011 11:19:52 AM

SAN JOSE, Calif., Oct. 31, 2011 /PRNewswire/ -- Baxano, Inc., a Silicon Valley based medical device company and manufacturer of the iO-Flex® System for spinal decompression surgery, announces a rapid expansion of its sales infrastructure to meet the surging demand for its products.

This continued expansion in the field infrastructure will help increase Baxano's reach into new and existing accounts throughout the U.S. while providing greater support to surgeons in their efforts to help treat a growing number of patients suffering from lumbar spinal stenosis (LSS), a disease that currently affects roughly 3 million adults annually.

Tony Recupero, President & CEO of Baxano, commented, "We are very optimistic about Baxano's current success and future prospects. Our monthly sales have grown 300% during the first three quarters of 2011 and Q4 is showing even stronger growth rates. We are expanding our sales coverage so that we can continue to deliver this very innovative technology to surgeons who are treating LSS patients."

Baxano's flagship iO-Flex® System is the first minimally invasive set of flexible instruments designed to target lumbar stenosis in the central canal, lateral recess and neural foramen, with minimal disruption to the patient's healthy anatomy. It is the only treatment alternative that is able to reach and remove tissue that creates pressure on multiple nerve roots through a single incision.

The Company is also currently enrolling patients in two separate post-market trials (iO-Flex Study and STRiDE) to further demonstrate outcomes and economics relative to traditional treatments for LSS.

About Baxano, Inc.

Baxano, Inc., based in San Jose, California, is a privately held company which was founded in 2005 with the vision to create flexible tools to provide precision lumbar decompression from the "inside out." These important platform technologies will form the basis for future product offerings.

Baxano's mission is to develop innovative tools that restore spine function, preserve healthy tissue, and enable a better quality of life for the patients we serve.

Along with our dedication to advanced technology development, Baxano is focused on providing exceptional value to patients, customers, investors and employees. For more information about Baxano and its products, please visit: www.baxano.com

Contact:
Amie Borgstrom
Vice President, Marketing
Phone: 408-514-2217
aborgstrom@baxano.com

SOURCE Baxano, Inc.


Read at BioSpace.com


comments powered by Disqus
Baxano
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES